Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Zhang

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Journal of Integrative Medicine|November 22, 2014
Cytotoxic genes from traditional Chinese medicine inhibit tumor growth both in vitro and in vivoYuan-hui Zhang, Yuan Wang, Ali Hussein Yusufali, et al.
Journal of Medicinal Chemistry|February 21, 2015
Development of novel ACK1/TNK2 inhibitors using a fragment-based approachHarshani R Lawrence, Kiran Mahajan, Yunting Luo, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 26, 2019
Single vs multiple fraction palliative radiation therapy for bone metastases: Cumulative meta-analysisRonald Chow, Peter Hoskin, Steven E Schild, et al.
Biomolecules|February 25, 2022
Milk-Derived Proteins and Peptides in Head and Neck Carcinoma TreatmentTheresa Wang, Xinyi Liu, Yah Ying Ng, et al.
Cell Research|January 24, 2019
Author Correction: Gene and mutation independent therapy via CRISPR-Cas9 mediated cellular reprogramming in rod photoreceptorsJie Zhu, Chang Ming, Xin Fu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 2, 2026
Prevalence of antibody drug conjugated-induced nausea and vomiting (ADCINV) in patients with cancerRonald Chow, Daniel Zhang, Samy Kannout, et al.
CNS Oncology|November 27, 2019
Clinical activity of the <i>EGFR</i> tyrosine kinase inhibitor osimertinib in <i>EGFR</i>-mutant glioblastomaIgor Makhlin, Ryan D Salinas, Daniel Zhang, et al.
Nature Cancer|November 5, 2021
Low neoantigen expression and poor T-cell priming underlie early immune escape in colorectal cancerPeter M K Westcott, Nathan J Sacks, Jason M Schenkel, et al.
JCI Insight|December 26, 2024
Endothelial response to blood-brain barrier disruption in the human brainAndrew Gould, Yu Luan, Ye Hou, et al.
Oncogene|June 13, 2020
Ribosomal protein S11 influences glioma response to TOP2 poisonsChidiebere U Awah, Li Chen, Mukesh Bansal, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Journal of Integrative Medicine|November 22, 2014
Cytotoxic genes from traditional Chinese medicine inhibit tumor growth both in vitro and in vivoYuan-hui Zhang, Yuan Wang, Ali Hussein Yusufali, et al.
Journal of Medicinal Chemistry|February 21, 2015
Development of novel ACK1/TNK2 inhibitors using a fragment-based approachHarshani R Lawrence, Kiran Mahajan, Yunting Luo, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 26, 2019
Single vs multiple fraction palliative radiation therapy for bone metastases: Cumulative meta-analysisRonald Chow, Peter Hoskin, Steven E Schild, et al.
Biomolecules|February 25, 2022
Milk-Derived Proteins and Peptides in Head and Neck Carcinoma TreatmentTheresa Wang, Xinyi Liu, Yah Ying Ng, et al.
Cell Research|January 24, 2019
Author Correction: Gene and mutation independent therapy via CRISPR-Cas9 mediated cellular reprogramming in rod photoreceptorsJie Zhu, Chang Ming, Xin Fu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 2, 2026
Prevalence of antibody drug conjugated-induced nausea and vomiting (ADCINV) in patients with cancerRonald Chow, Daniel Zhang, Samy Kannout, et al.
CNS Oncology|November 27, 2019
Clinical activity of the <i>EGFR</i> tyrosine kinase inhibitor osimertinib in <i>EGFR</i>-mutant glioblastomaIgor Makhlin, Ryan D Salinas, Daniel Zhang, et al.
Nature Cancer|November 5, 2021
Low neoantigen expression and poor T-cell priming underlie early immune escape in colorectal cancerPeter M K Westcott, Nathan J Sacks, Jason M Schenkel, et al.
JCI Insight|December 26, 2024
Endothelial response to blood-brain barrier disruption in the human brainAndrew Gould, Yu Luan, Ye Hou, et al.
Oncogene|June 13, 2020
Ribosomal protein S11 influences glioma response to TOP2 poisonsChidiebere U Awah, Li Chen, Mukesh Bansal, et al.
Pageof 5